← Leaderboards
Bertram L. Jacobs
Arizona State University-Tempe Campus
$17,600,063
Attributed
$17,600,063
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,600,063 · 11
By mechanism
U01$7,975,488 · 2
R01$7,580,455 · 3
R21$2,029,120 · 5
R13$15,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Arizona State University-Tempe Campus
Same institution · by research overlap
- Yuri L Lyubchenko$11,856,158
Others in their field
Top investigators on “Vaccinia Virus”
- George R Painter · Chimerix, Inc.$36,309,505
- Daniel F. Hoft · Saint Louis University$26,271,892
- Rama Rao Amara · Emory University$21,210,426
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$18,568,832
- Stewart H Shuman · Sloan-Kettering Institute For Cancer Res$15,348,129
- Don J Diamond · University Of Southern California$13,418,497
Research focus
Vaccinia VirusVirusVirulenceAnimalsCellsSmallpoxVaccine DevelopmentVirus DiseasesPreventMutantInterferonsAttenuatedVaccinationLeadN-TerminalPoxviridaeProteinsHomologous GenePathogenesisE3l GeneInfectionMonkeypox VirusOrthopoxvirusVaccines
Grant awards (35)
Safer, More Effective Mpox/Smallpox Vaccine$431,750
R21 · FY2025 · AI · contact PI
Monkeypox virus, Interferon, and Necroptosis$420,608
R01 · FY2024 · AI · contact PI
Monkeypox virus, Interferon, and Necroptosis$418,253
R01 · FY2023 · AI · contact PI
Monkeypox virus, Interferon, and Necroptosis$541,174
R01 · FY2022 · AI · contact PI
Arsenite-induced necroptosis$189,761
R21 · FY2022 · ES · contact PI
Monkeypox virus, Interferon, and Necroptosis$476,833
R01 · FY2021 · AI · contact PI
Arsenite-induced necroptosis$229,492
R21 · FY2021 · ES · contact PI
Monkeypox virus, Interferon, and Necroptosis$538,257
R01 · FY2020 · AI · contact PI
DsRNA Characterization in Monkeypox-infected Cells$671,400
R01 · FY2016 · AI · contact PI
DsRNA Characterization in Monkeypox-infected Cells$692,150
R01 · FY2015 · AI · contact PI
DsRNA Characterization in Monkeypox-infected Cells$382,999
R01 · FY2014 · AI · contact PI
DsRNA Characterization in Monkeypox-infected Cells$360,019
R01 · FY2013 · AI · contact PI
DsRNA Characterization in Monkeypox-infected Cells$382,999
R01 · FY2012 · AI · contact PI
XVII International Poxvirus, Asfivirus and Indorviurs Symposium$15,000
R13 · FY2010 · AI · contact PI
Disabling Vaccinia IFNr: A New Smallpox Vaccine$784,358
U01 · FY2008 · AI · contact PI
Development of a Safer Smallpox Vaccine$1,124,042
U01 · FY2007 · AI · contact PI
Disabling Vaccinia IFNr: A New Smallpox Vaccine$777,692
U01 · FY2007 · AI · contact PI
Role of the E3L gene in poxvirus pathogenesis$350,998
R01 · FY2007 · AI · contact PI
Development of a Safer Smallpox Vaccine$1,285,455
U01 · FY2006 · AI · contact PI
Disabling Vaccinia IFNr: A New Smallpox Vaccine$418,119
U01 · FY2006 · AI · contact PI
Role of the E3L gene in poxvirus pathogenesis$353,122
R01 · FY2006 · AI · contact PI
Disabling Vaccinia IFNr: A New Smallpox Vaccine$108,388
U01 · FY2006 · AI · contact PI
Development of a Safer Smallpox Vaccine$1,658,791
U01 · FY2005 · AI
Development of a post-exposure vaccine for smallpox$1,097,389
R01 · FY2005 · AI
Disabling Vaccinia IFNr: A New Smallpox Vaccine$493,250
U01 · FY2005 · AI
Role of the E3L gene in poxvirus pathogenesis$353,306
R01 · FY2005 · AI
Development of a Safer Smallpox Vaccine$932,553
U01 · FY2004 · AI
Role of the E3L gene in poxvirus pathogenesis$345,236
R01 · FY2004 · AI
Development of a Safer Smallpox Vaccine$392,840
U01 · FY2003 · AI
Mucosal Immunization with a Vaccinia Virus-Based Vector$224,250
R21 · FY2003 · AI
An Improved Vaccine for Protection Against Smallpox$224,250
R21 · FY2003 · AI
Role of the E3L gene in poxvirus pathogenesis$195,712
R01 · FY2003 · AI
Role of the E3L gene in poxvirus pathogenesis$289,850
R21 · FY2002 · AI
Mucosal Immunization with a Vaccinia Virus-Based Vector$224,875
R21 · FY2002 · AI
An Improved Vaccine for Protection Against Smallpox$214,892
R21 · FY2002 · AI